| 1 |
32603908 | Zoledronate decreases CTLA-4 in vivo and in vitro independently of its action on bone resorption. | 2020 Sep |
1 |
| 2 |
28299378 | Factors associated with acute-phase response of bisphosphonate-naïve or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate. | 2017 Jun |
9 |
| 3 |
21956654 | Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administration. | 2012 Jan |
1 |
| 4 |
22676573 | The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone mass. | 2012 Dec |
1 |
| 5 |
20554708 | Characterization of and risk factors for the acute-phase response after zoledronic acid. | 2010 Sep |
1 |
| 6 |
3124942 | The acute-phase response after bisphosphonate administration. | 1987 Dec |
2 |